KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Accounts Payables (2016 - 2025)

Biogen (BIIB) has 17 years of Accounts Payables data on record, last reported at $432.0 million in Q4 2025.

  • For Q4 2025, Accounts Payables rose 1.84% year-over-year to $432.0 million; the TTM value through Dec 2025 reached $432.0 million, up 1.84%, while the annual FY2025 figure was $432.0 million, 1.84% up from the prior year.
  • Accounts Payables reached $432.0 million in Q4 2025 per BIIB's latest filing, up from $413.1 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $589.2 million in Q4 2021 and bottomed at $354.5 million in Q2 2024.
  • Average Accounts Payables over 5 years is $427.2 million, with a median of $423.4 million recorded in 2024.
  • Peak YoY movement for Accounts Payables: grew 29.52% in 2021, then dropped 21.21% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $589.2 million in 2021, then decreased by 16.58% to $491.5 million in 2022, then fell by 17.95% to $403.3 million in 2023, then grew by 5.18% to $424.2 million in 2024, then grew by 1.84% to $432.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $432.0 million in Q4 2025, $413.1 million in Q3 2025, and $408.4 million in Q2 2025.